'White clot syndrome';Todliche zentrale Lungenembolien unter Heparintherapie: 'White clot syndrome'

Schweizerische Medizinische Wochenschrift

Volumn 127, Issue 18, 1997, Pages 762-765

  Canova, C R ^a,c   Cantieni, R ^b   Zellweger, U ^b   Reinhart, W H ^a  

^a Medizinische Klinik   (Switzerland)

^b Regionalspital Ilanz ^*

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT; AUTOANTIBODY; IMMUNOGLOBULIN G;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT; CASE REPORT; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; THROMBOSIS; CHEMICALLY INDUCED DISORDER; FATALITY; IMMUNOLOGY; LUNG EMBOLISM; PATHOPHYSIOLOGY; PULMONARY ARTERY; SYNDROME; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

AGED; ANTICOAGULANTS; AUTOANTIBODIES; FATAL OUTCOME; FEMALE; HEPARIN; HUMANS; IMMUNOGLOBULIN G; PLATELET AGGREGATION; PULMONARY ARTERY; PULMONARY EMBOLISM; SYNDROME; THROMBOCYTOPENIA;

EID: 0030918019     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS et al.: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335.
2. Killer S, Zoppi M, Künzi UP, Hess T, Galeazzi RL et al.: Heparininduzierte Thrombozytopenie (HIT) - Ergebnisse aus dem Comprehensive Hospital Drug Monitoring (CHDM). Schweiz Med Wochenschr 1995; 125: 2518-2522.
3. AbuRahma AF, Boland JP, Witsberger T: Diagnostic and therapeutic strategies of white clot syndrome. Am J Surg 1991; 162: 175-179.
4. Aster RH: Heparin-induced thrombocytopenia and thrombosis [Editorial]. N Engl J Med 1995; 332: 1374-1376.
5. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JAI et al.: Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84: 3691-3699.
6. Boshkov LK, Wartekin TE, Hayward CP, Andrew M, Kelton KG: Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Hematol 1993; 84: 322-328.
7. Drakos P, Uziely B, Nagler A, Gillis S, Eldor A: Successful administration of low molecular heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis. Haemostasis 1993; 23: 259-262.
8. Kleinschmidt S, Seyfert UT: Heparin-associated thrombocytopenia (HAT) - still a diagnostic and therapeutical problem in clinical practice. Angiology 1995; 46: 37-44.
9. Warkentin TE, Kelton JG: A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-507.
10. Greinacher A: Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 1995; 21: 106-116.
11. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V et al.: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 1994; 34: 381-385.
12. Greinacher A, Liebenhoff U, Kiefel V, Presek P, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation - a possible new indication for high dose i.v. IgG. Thromb Haemost 1994; 71: 641-645.
13. Hunter JB, Lonsdale RJ, Wenham PW, Frostick SP: Heparin induced thrombosis: an important complication of heparin prophylaxis for thromboembolic disease in surgery. Br Med J 1993; 53-55.
14. Kelton JG, Smith JW, Warkentin TE: Immunglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83: 3232-3239.
15. Kikta MJ, Keller MP, Humphrey PW, Silver D: Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? Surgery 1993; 114: 705-710.
16. Mickley V: Therapie des heparin-induzierten Thrombose-Thrombozytopenie-Syndroms mit Immunglobulinen. Dtsch Med Wochenschr 1993; 118: 923-924.
17. Moore JA, Bruket MW, Puri S, Temesy-Armos P, Lachant N, Skeel R: Ancrod infusion for anticoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia. Cathet Cardiovasc Diagn 1994; 32: 286-287.
18. Nand S: Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis. Am J Hematol 1993; 45: 352-353.